Erasca (ERAS) Interest & Investment Income (2020 - 2026)
Powered by 
Analysis
Erasca (ERAS) Interest & Investment Income (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Erasca | 5.02 Bn | 5.02 Bn | - | 3.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.60 Mn |
| Mar 31, 2026 | 4.45 Mn |
| Dec 31, 2025 | 3.57 Mn |
| Sep 30, 2025 | 3.97 Mn |
| Jun 30, 2025 | 4.33 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Dec 31, 2024 | 5.28 Mn |
| Sep 30, 2024 | 5.87 Mn |
| Jun 30, 2024 | 5.04 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Dec 31, 2023 | 4.24 Mn |
| Sep 30, 2023 | 4.35 Mn |
| Jun 30, 2023 | 4.25 Mn |
| Mar 31, 2023 | 3.88 Mn |
| Dec 31, 2022 | 2.88 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 388,000.00 |
| Mar 31, 2022 | 114,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Sep 30, 2021 | 49,000.00 |